A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy
Nature Genetics2014Vol. 47(1), pp. 39–46
Citations Over TimeTop 1% of 2014 papers
Mikko Muona, Samuel F. Berkovic, Leanne M. Dibbens, Karen Oliver, Snezana Maljevic, Marta A. Bayly, Tarja Joensuu, Laura Canafoglia, Silvana Franceschetti, Roberto Michelucci, Salla Markkinen, Sarah E. Heron, Michael S. Hildebrand, Eva Andermann, Frédérick Andermann, Antonio Gambardella, Paolo Tinuper, Laura Licchetta, Ingrid E. Scheffer, Chiara Criscuolo, Alessandro Filla, Edoardo Ferlazzo, Jamil Ahmad, Adeel Ahmad, Betül Baykan, Edith Said, Meral Topçu, P. Riguzzi, Mary D. King, Çiğdem Özkara, Danielle M. Andrade, Bernt A. Engelsen, Arielle Crespel, Matthias Lindenau, Ebba Lohmann, Veronica Saletti, João Massano, Michael Privitera, Alberto J. Espay, Brice Kauffmann, Michael Duchowny, Rikke S. Møller, Rachel Straussberg, Zaid Afawi, Bruria Ben‐Zeev, Kaitlin E. Samocha, Mark J. Daly, Steven Petrou, Holger Lerche, Aarno Palotie, Anna-Elina Lehesjoki
Related Papers
- → Levetiracetam in progressive myoclonic epilepsy(2004)68 cited
- → Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam(2011)10 cited
- → Levetiracetam in three cases of progressive myoclonus epilepsy(2007)10 cited
- → Progressive Myoclonus Epilepsy with Adolescent Onset: Clinical Features and Diagnosis(2015)
- → Myoclonus improvement after seizures in progressive myoclonic epilepsy type 7: a case report(2024)